Company Overview of HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc., a pharmaceutical company, develops small molecule therapeutics based on its short chain fatty acid derivative (SCFAD) technologies to treat anemia and other blood disorders. Its products include Hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia; and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was formerly known as Hemagenex Pharmaceuticals, Inc. and changed its name in 2008. HemaQuest Pharmaceuticals, Inc. was founded in 2007 and is based in San Diego, California.
11995 El Camino Real
San Diego, CA 92130
Founded in 2007
Key Executives for HemaQuest Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact HemaQuest Pharmaceuticals, Inc., please visit www.hemaquest.com. Company data is provided by Capital IQ. Please use this form to report any data issues.